BAA research area 001: development of vaccine candidates for biodefense, antimicrobial resistant (AMR) infections and emerging infectious diseases
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93023C00018
- Awardee
-
Access To Advanced Health Institute UEI EMQ1ANLATYS6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,018,496
Award facts
- Opportunity
-
- BAA20221 Solicitation number
- Contract value 27% obligated
-
- $5,018,496.05 Current, with exercised options
- $18,576,013.05 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 19 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Seattle, WA 98102, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $109,606 | |
| Exercise an Option | $841,495 | |
| Exercise an Option | $2,830,744 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $426,466 | |
| Original award | $810,185 |
Show all 13
About this award
This is a $18,576,013.05 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute located in Seattle, Washington. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant infections, and emerging infectious diseases, under NIAID's Broad Agency Announcement (BAA) Research Area 001. AAHI has experience as both a prime contractor and subcontractor on federal vaccine R&D contracts and grants with agencies such as NIH, ASPR, Army, and DHA. This contract does not have a set-aside designation and is set to run through June 2025.
Quick answers
Who was awarded contract 75N93023C00018?
75N93023C00018 was awarded to Access To Advanced Health Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 5, 2023.
How much is contract 75N93023C00018 worth?
The government has obligated $5,018,496 on 75N93023C00018. Its potential value, with all options, is $18,576,013.
Was contract 75N93023C00018 competed?
The extent of competition for 75N93023C00018 was full and open competition. The government received 19 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award